🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Personalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle Study

RecruitingNAAges 18 Years - anyAllUniversity of Zurich
NCT07082595 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs. Disability is largely driven by mobility deficits caused by impaired gait. Effective treatments are available to restore lower limb function and improve gait, but response to treatment varies greatly from patient to patient and often shows only small effect sizes. Addressing this heterogeneity requires personalization, a concept referred to precision neurorehabilitation. StimuLOOP.PD-Sleep intends to foster structured and reproducible methods for precision neurorehabilitation of gait in PD. The investigators will conduct a proof-of-concept study to investigate a sleep intervention tailored to the individual patient in the context of motor rehabilitation. • Targeted auditory stimulation during sleep (TASS): The investigato

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Idiopathic Parkinson's disease with gait and postural stability deficits * ≥18 years of age * UPDRS III gait scores 1-3 * UPDRS III postural instability scores 1-3 * Prescribed rehabilitation therapy * Informed consent as documented by signature * Adjustments in dopaminergic medication and DBS stimulation to improve Exclusion Criteria: * Cognitive impairment, Montreal Cognitive Assessment (MoCa) \< 20 * Other neurological or medical condition that caused sustained clinically relevant gait and/or postural stability deficits * History of a physical or neurological condition that interferes with study procedures * Social and/or personal circumstances that interfere with the ability to return for assessments * Patients taking benzodiazepines or Z-drugs that have a significant effect on sleep EEG * Recent DBS implant (≤ 6 months) * Inability to perform outcome assessments without walking aid * Skin disorders/problems/allergies in face/ear area that could worsen with electrode application (e.g. nickel allergy)
💊

What it tests

  • TASS Intervention (Sham)
  • TASS Intervention (Verum)
📍

Where

1 site
University of Zurich
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy